Results 211 to 220 of about 25,687 (255)

Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents. [PDF]

Mol Divers
Almulhim M, Ghasemian A, Memariani M, Karami F, Yassen ASA, Alexiou A, Papadakis M, Batiha GE.   +7 more
europepmc   +1 more source

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang, Mingzhao Li, Kai Yao, Zhuyinjun Zong, Yifan Chang, Yongda Liu, Chao Cai, Fadi Mousa Al Kalailah, Shancheng Ren, Guohua Zeng, Di Gu   +10 more
wiley   +1 more source

HeteroKGRep: Heterogeneous Knowledge Graph based Drug Repositioning. [PDF]

Knowl Based Syst
Ceskoutsé RFT, Bomgni AB, Gnimpieba Zanfack DR, Agany DDM, Thomas BB, Zohim EG.   +5 more
europepmc   +1 more source

Improving drug repositioning accuracy using non-negative matrix tri-factorization. [PDF]

Sci Rep
Li Q, Wang Y, Wang J, Zhao C.
europepmc   +1 more source

Publisher Correction: Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy. [PDF]

Sci Rep
Jafari Z, Javadirad SM, Yazdi Rouholamini SE.   +2 more
europepmc   +1 more source

Improving drug repositioning with negative data labeling using large language models. [PDF]

J Cheminform
Picard M, Leclercq M, Bodein A, Scott-Boyer MP, Perin O, Droit A.   +5 more
europepmc   +1 more source

Repositioning Drugs for Psychiatry.

Avicenna journal of medical biotechnology
openaire   +1 more source

Drug repositioning: a brief overview [PDF]

Journal of Pharmacy and Pharmacology, 2020
Abstract Objectives Drug repositioning, that is, the use of a drug in an indication other than the one for which it was initially marketed, is a growing trend. Its origins lie mainly in the attrition experienced in recent years in the field of new drug discovery.
Jean-Pierre Jourdan, Christophe Rochais, Patrick Dallemagne   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Drug Repositioning in Oncology

American Journal of Therapeutics, 2021
Background: The worldwide increase in the occurrence of cancer associated with the limitations of immunotherapy and the emergence of resistance have impaired the prognosis of cancer patients, which leads to the search for alternative treatment methods.
Marissa B, Serafin, Angelita, Bottega, Taciéli F, da Rosa, Catrine S, Machado, Vitória S, Foletto, Silvana S, Coelho, Augusto D, da Mota, Rosmari, Hörner   +7 more
openaire   +2 more sources

Drug repositioning for orphan diseases [PDF]

Briefings in Bioinformatics, 2011
The need and opportunity to discover therapeutics for rare or orphan diseases are enormous. Due to limited prevalence and/or commercial potential, of the approximately 6000 orphan diseases (defined by the FDA Orphan Drug Act as
Anil G Jegga, Cheng Zhu, Minlu Zhang
exaly   +3 more sources